Trial intelligence / Profile preview

Safety and Effectiveness of Artequin Paediatric in African Children with Malaria

NCT00978172Phase 4Completed

Sponsor
Mepha
Start
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of artesunate + mefloquine in Plasmodium falciparum malaria, sponsored by Mepha. Started Dec 2007; status: completed.

02

Drugs

artesunate + mefloquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00978172.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00978172.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call